Full list of papers 2011-2006
Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). Inc Squire IB The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2011 Aug 6 Epub
Dhillon OS, Narayan HK, Quinn PA, Squire IB, Davies JE, Ng LL. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: Comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP. Am Heart J. 2011 Jun 161 6 1163-70
Weir RA, Clements S, Steedman T, Dargie HJ, McMurray JJ, Squire IB, Ng LL. Plasma TIMP-4 Predicts Left Ventricular Remodeling After Acute Myocardial Infarction. J Card Fail. 2011 Jun 17 6 465-71
Klip IT, Voors AA, Anker SD, Hillege HL, Struck J, Squire I, van Veldhuisen DJ, Dickstein K; for the OPTIMAAL investigators. Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart. 2011 Jun 97 11 892-898
Narayan H, Dhillon OS, Quinn P, Struck J, Squire IB, Davies JE, Ng LL. C-Terminal Provasopressin (Copeptin) as Prognostic Marker after Acute Non ST Elevation Myocardial Infarction - Leicester Acute Myocardial Infarction Peptide II (LAMP II) study. Clin Sci (Lond). 2011 Jul 1 121 2 79-89
Clark AL, Johnson MJ, Squire I. Does home oxygen benefit people with chronic heart failure? BMJ. 2011 Feb 4 372 d234
West RM, Cattle BA, Bouyssie M, Squire I, de Belder M, Fox KA, Boyle R, McLenachan JM, Batin PD, Greenwood DC, Gale CP. Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. Eur Heart J. 2011 Mar 32 6 706-11
Ng LL, Khan SQ, Narayan H, Quinn P, Squire IB, Davies JE. Proteinase 3 and prognosis of patients with acute myocardial infarction. Clin Sci (Lond). 2010 Dec 3 120 6 231-8
Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010 Sep 11 376 9744 875-85
Maznyczka A, Squire IB. Cough syncope--a diagnosis under pressure. Lancet 2010 Sep 18 376 9739 486
Kelly D, Squire IB, Khan SQ, Dhillon O, Narayan H, Ng KH, Quinn P, Davies JE, Ng LL. Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction. Am J Cardiol. 2010 Aug 15 106 4 477-82
Squire IB, Nelson CP, Ng LL, Jones DR, Woods KL, Lambert PC. Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction; Results from 4702 index cases in routine practice. Clin Sci (Lond). 2010 118 527-35
Dhillon OS, Khan SQ, Narayan HK, Ng KH, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study. J Am Coll Cardiol. 2010 Jul 6 56 2 125-33
Kelly D, Khan SQ, Dhillon O, Quinn P, Struck J, Squire IB, Davies JE, Ng LL. Procalcitonin as a prognostic marker in patients with acute myocardial infarction. Biomarkers. 2010 Jun 15 4 325-31
Weir RA, Balmain S, Steedman T, Ng LL, Squire IB, Rumley A, Dargie HJ, Lowe GD. Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction. J Thromb Thrombolysis. 2010 May 29 4 421-8
Narayan H, Mohammed N, Quinn PA, Squire IB, Davies JE, Ng LL. Activation of a novel natriuretic endocrine system in humans with heart failure. Clin Sci (Lond). 2010 Mar 118 5 367-74
Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA; HEAAL Investigators. Squire IB et al Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet. 2009 Nov 28 374 9704 1840-8
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators (incl Squire IB), Freij A, Thorsén M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009 Sep 10 361 11 1045-57
Blackledge HM, Squire IB. Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation; Results from a large, population-based cohort with first intervention 1995 - 2004. Heart. 2009 Feb 95 4 304-11
Bhandari SS, Loke I, Davies JE, Squire IB, Struck J, Ng LL. Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin Sci (Lond). 2009 Feb 116 3 257-63
CRT Survey Scientific Committee. European cardiac resynchronization therapy survey: rationale and design. Eur.J.Heart Fail. 2009; 11: 326-330
Mega JL, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, Hricak V, Barnathan ES, Bordes P, Witkowski A, Markov V, Oppenheimer L, Gibson CM; ATLAS ACS-TIMI 46 study group. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet 2009; 374: 29-38. PMID 1953 9361
Dhillon OS, Khan SQ, Narayan HK, Ng KH, Mohammed N, Quinn PA, Squire IB, Davies JE, Ng LL. Matrix Metalloproteinase-2 predicts mortality in patients with acute coronary syndrome. Clin.Sci. 2009. e-pub ahead of print. PMID 19583569
Weir RAP, Mark PB, Petrie CJ, Clements S, Steedman T, Ford I, Ng LL, Squire IB, McMurray JJV, Dargie HJ. Left ventricular remodelling after acute myocardial infarction; does eplerenone have an effect? Am Heart J 2009;157:1088-96
Voors AA, von Haehling, S, Anker SD, Hillege HL, Struck S, Hartmann O, Bergmann A, Squire IB, van Veldhuisen DJ, Dickstein K, for the OPTIMAAL investigators. C-Terminal Provasopressin (Copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction. Results from the OPTIMAAL study. Eur. Heart J. 2009 30: 1187-1194; doi:10.1093/eurheartj/ehp098
Khan SQ, Narayan H, Ng KH, Dhillon OS, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL. N-terminal pro B type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome. Clin.Sci. 2009; 117: 31-39.
Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL. Growth differentiation factor -15 as a prognostic marker in patients with acute myocardial infarction. Eur. Heart J. 2009; 30: 1057-1065; doi:10.1093/ eurheartj/ehn600
Kelly D, Squire IB, Khan SQ, Quinn P, Struck J, Morgenthaler NG, Davies JE, Ng LL. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction. J. Card.Fail. 2008; 14: 739-745
Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, Samani NJ, Squire IB. Plasma Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after Acute Myocardial Infarction. European Heart Journal 2008; doi:10.1093/eurheartj/ehn315.
Kelly D, Cockerill G, Ng LL, Thompson M, Samani NJ, Squire IB. Circulating Stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur. J. Heart Failure 2008; 10: 133-9. (Epub 2008 Jan 30)
ARISE Trial Investigators. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371 :1726-8.
HAT Investigators. Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med. 2008; 358: 1793-804
Stone MA, Khunti K, Squire IB, Paul S. Impact of co-morbid diabetes on quality of life and perception of angina pain in people with angina registered with general practitioners in the UK. Quality of Life Research 2008; Epub June 2008; doi 10.1007/s11136-008-9363-0
Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL. Plasma B-type natriuretic peptide as an indicator of long term survival after acute myocardial infarction: comparison with midregional Pro-atrial natriuretic peptide. The LAMP (Leicester Acute Myocardial Infarction Peptide study). J.Am.Coll.Cardiol. 2008; 51; 1857-1864
Nelson CP, Lambert PC, Squire IB, Jones DR. Relative Survival - What Can Cardiovascular Disease Learn From Cancer ? Eur. Heart J. 2008; 29: 941-7 (Epub Mar 6. 2008; doi: 10.1093/eurheartj/ehn079)
Turner DA, Khunti K, Paul S, Stone M, Juarez-Garcia A, Squire IB. A disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cost-effectiveness analysis. Heart. 2008 May 1. [Epub ahead of print] PMID: 18450843
Nelson CP, Lambert PC, Squire IB, Jones DR. Flexible parametric models for relative survival, with application in coronary heart disease. Statistics in Medicine 2007; 26: 5486-98
Orn S, Manhenke C, Squire I, Ng LL, Anand I, Dickstein K. Plasma Matrix Metalloproteinase -2, -9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function. J.Cardiac Failure 2007; 13: 843-849
Orn S, Manhenke C, Anand IS, Squire I, Nagel E, Edvardsen T, Dickstein K. Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction. Am J Cardiol. 2007; 9:1109-14. Epub 2007 Feb 21
Khan SQ, O’Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol. 2007; 49: 1525-32.
Khan SQ, Dhillon OS, O’Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. C-terminal proVasopressin (Copeptin) as a Novel and Prognostic Marker In Acute Myocardial Infarction- Leicester Acute Myocardial Infarction Peptide (LAMP) Study. Circulation 2007; 115: 2103-10. Epub 2007 Apr 9
Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, Samani NJ, Squire IB. Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. European Heart Journal 2007; doi: 10.1093/eurheartj/ehm003
Khunti K, Stone M, Paul S, Baines J, Gisborne L, Farooqi A, Luan X, Squire IB. Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart 2007 19 February 2007, 10.1136/hrt.2006.103002
Ng LL, O'Brien RJ, Quinn PA, Squire IB, Davies JE. Oxygen-regulated protein-150 and prognosis following myocardial infarction. Clin. Sci. 2007; 112 : 477-484
Estensen ME, Hognestad A, Syversen U, Squire I, Ng L, Kjekshus J, Dickstein K, Omland T. Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction. Am. Heart J. 2006; 152: 927.e1-927.e6
31. Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland, T, Squire IB, Frøland SS, Mollnes TE, Dickstein K, Aukrust P. Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction. J Card Fail. 2006;12: 659-63
Newton JD, Squire IB. Plasma glucose and haemoglobin in the assessment of prognosis following first hospitalisation for heart failure. Heart 2006; 92: 1441-6
Ng LL, Pathik B, Loke IW, Squire IB, Davies JE. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. Am. Heart J. 2006; 152: 94-101
Editorials (2011-2006)
Shortness of breath, prescription of bronchodilators and the risk of myocardial infarction. J Hypertension 2009; 27: 1358-1359(Editorial)
Squire IB. Assessing prognosis in heart failure: you can see a lot if you look, but more if you look again. Eur Heart J. 2008; 29: 959-60 (Epub 2008) (Editorial)
Reviews (2011-2006)
Farooq M, Qureshi AS, Squire IB. Early management of ST elevation myocardial infarction: a review of practice. Expert Opin Pharmacother. 2007; 8: 401-13
Squire IB. Overview of complicated acute MI with LVSD. MIMS Advanced. September 2006
